Event Brief
FDA Approves Leucovorin for Rare Genetic Disorder
Filed: Mar 10, 2026 at 10:04 AM ET
Summary: Leucovorin is now the first approved treatment for a rare genetic disorder, following its controversial promotion for autism.
WHO: Food and Drug Administration
WHAT: Approved leucovorin as a treatment for a rare genetic disorder
WHEN: Mar 10, 2026 at 9:17 AM ET
WHERE: USA
WHY: To provide a treatment for cerebral folate deficiency
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →